BECN1 and cancer: In addition, a PDA‐based NP system was developed to enhance PTT in cancer cells by inducing autophagy.[329] The PDA NPs were modified with PEG for stability and further functionalized with Beclin‐1‐derived peptides to stimulate autophagy and RGD peptides for enhanced tumor targeting.